Metabolic & Incretin · Research deep dive
Tirzepatide: the cited literature
Every study referenced in the Tirzepatide monograph, with plain-language context, PubMed links to read each paper yourself, and how the compound appears in the dosing literature.
How this compound is studied
Across the dosing literature, Tirzepatide is studied at 2.5 mg – 15 mg per administration, typically once weekly. The reference walkthrough below maps each citation to what it actually showed.
References covered
Tirzepatide once weekly in T2D
NEJM, 2021
Tirzepatide for obesity (SURMOUNT-1)
NEJM, 2022
The full walkthrough is for subscribers
Unlock the evidence grading, what each study actually found, how the trials dosed it, reported safety signals, open questions, and PubMed links for Tirzepatide.